APOLLOHOSP · NSE
Apollo Hospitals
Phase 4 · Capital Return
Profitable, cash-generative, and returning capital to shareholders through dividends.
Phase 1
Startup
Phase 2
Hyper Growth
Phase 3
Operating Leverage
Phase 4
Capital Return
Phase 5
Decline
Revenue growth (YoY)
15.8%
Mar 2026 vs Mar 2025
Net profit growth (YoY)
33.1%
Operating cash flow
₹2856 Cr
Mar 2026
Returning capital?
Yes
Last dividend ex-date 2026-08-13
Revenue, profit & operating cash flow
₹ crore, by fiscal year
RevenueNet profitOperating cash flowRevenue ends at ₹25228 Cr. Net profit ends at ₹2003 Cr. Operating cash flow ends at ₹2856 Cr.
Judge management on
Capital allocation — are dividends sized sensibly against free cash flow?
Key metric to watch
Free cash flow and the dividend payout ratio.
Typically valued on
Price/earnings and dividend yield.
| Fiscal year | Revenue | Net profit | Operating cash flow |
|---|---|---|---|
| Mar 2021 | ₹10560 Cr | ₹137 Cr | ₹1265 Cr |
| Mar 2022 | ₹14663 Cr | ₹1108 Cr | ₹1696 Cr |
| Mar 2023 | ₹16612 Cr | ₹844 Cr | ₹1377 Cr |
| Mar 2024 | ₹19059 Cr | ₹935 Cr | ₹1920 Cr |
| Mar 2025 | ₹21794 Cr | ₹1505 Cr | ₹2136 Cr |
| Mar 2026 | ₹25228 Cr | ₹2003 Cr | ₹2856 Cr |
Advertisement